Today, my voice is weaker and more strained, my walking halting and dependent on a cane, but my spirit remains unbroken because of each and every one of you. – Brian Wallach
Media Contact: Theresa Garner, [email protected]
- Read Brian Wallach’s full 2021 written congressional testimony
- Read Brian Wallach’s full 2020 written congressional testimony
- Read our press release on Brian Wallach’s 2019 congressional testimony
2021 Congressional Testimony
2019 Congressional Testimony
We will find cures for ALS. The only question is when. That answer depends on you.
Stay informed on I AM ALS’ progress and what you can do to help us make hope real.
Hummingbird Fund and I AM ALS partner to accelerate therapy approvals and access
We are thrilled to announce a new collaboration between I AM ALS and The Hummingbird Fund, a milestone towards achieving our shared mission of ending ALS through revolutionary policy advocacy.
NurOwn AdComm: What happened? What’s next?
There have been a lot of conversations about NurOwn’s Cellular, Tissue, and Gene Therapies Advisory Committee (AdComm) meeting that occurred on September 27, 2023, the subsequent Biologics License Applications (BLA) removal, and its perceived irregularities.